Related references
Note: Only part of the references are listed.The priorities of people with mesothelioma and their carers: A qualitative interview study of trial participation and treatment decisions
Anna C. Bibby et al.
EUROPEAN JOURNAL OF ONCOLOGY NURSING (2022)
Effect of targeted therapy and immunotherapy on advanced nonsmall-cell lung cancer outcomes in the real world
Aria Shokoohi et al.
CANCER MEDICINE (2022)
Hope and Worry An Interpretative Phenomenological Analysis of Psychological Experiences Associated With Targeted Drug Therapy Among Patients With Advanced Non-Small-Cell Lung Cancer
Li Ning et al.
CANCER NURSING (2022)
Associations of Uncertainty With Psychological Health and Quality of Life in Older Adults With Advanced Cancer
Haydee C. Verduzco-Aguirre et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Experiences and perspectives of individuals accessing CAR-T cell therapy: A qualitative analysis of online Reddit discussions
Kristina Jenei et al.
JOURNAL OF CANCER POLICY (2021)
Cancer immunotherapy: Pros, cons and beyond
Shuzhen Tan et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Cancer patients' experiences with immune checkpoint modulators: A qualitative study
Kari Ala-Leppilampi et al.
CANCER MEDICINE (2020)
Current Challenges in Cancer Immunotherapy: Multimodal Approaches to Improve Efficacy and Patient Response Rates
Manpreet Sambi et al.
JOURNAL OF ONCOLOGY (2019)
Adverse Events of Oncologic Immunotherapy and Their Management
Fedricker Diane Barber
ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING (2019)
Complexity and uncertainty in the critical care of cancer patients in the era of immunotherapy and targeted therapies
A. Carmona-Bayonas et al.
MEDICINA INTENSIVA (2018)
Patients' perceived tolerance of side effects in phase I cancer clinical trials: A qualitative study
A. Bredart et al.
EUROPEAN JOURNAL OF CANCER CARE (2017)
How does uncertainty shape patient experience in advanced illness? A secondary analysis of qualitative data
Simon Noah Etkind et al.
PALLIATIVE MEDICINE (2017)
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
J. B. A. G. Haanen et al.
ANNALS OF ONCOLOGY (2017)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
Larissa Shamseer et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
Larissa Shamseer et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Surviving with lung cancer: Medication-taking and oral targeted therapy
Karen E. Wickersham et al.
GERIATRIC NURSING (2014)
Communication Challenges for Chronic Metastatic Cancer in an Era of Novel Therapeutics
Sally E. Thorne et al.
QUALITATIVE HEALTH RESEARCH (2013)
Qualitative data: Cooking without a recipe
Melissa E. Graebner et al.
STRATEGIC ORGANIZATION (2012)